A New York group is expected to announce Wednesday that it has filed challenges to patents on Sovaldi in Argentina, Brazil, China, Russia and Ukraine.
High Cost of Hepatitis C Drug Prompts a Call to Void Its Patents
A New York group is expected to announce Wednesday that it has filed challenges to patents on Sovaldi in Argentina, Brazil, China, Russia and Ukraine.
No comments:
Post a Comment